Finance

Mga Listahan
Outlook: 20.4% bullish·6.8% bearish
Pumunta sa pagsusuri
MRK:NYSE
Merck
$145.19
-1.48%
(-2.18) 1D
$145.20
+0.01% (+0.0100)
Pagkalipas ng oras ng trabaho
Sarado: Okt 15, 4:04:43 PM GMT-4  ·   USD
Lahat ng simbolo
SimboloPresyoPalitan% ng Pagbabago
Bumubuo ng mga nangungunang insight para sa MRK...
Buksan
$149.70
Mataas
$152.34
Mababa
$144.91
Mkt. cap
358.21B
Avg. na dami
9.33M
Dami
0.00
Dividend
2.34%
Bawat tatlong buwang dividend
$0.85
Petsa ng ex-dividend
Set 15, 2026
P/E ratio
115.96
Mataas nang 52-wk
$156.92
Mababa nang 52-wk
$82.01
EPS
$1.25
Beta
0.21
Mga natitirang share
2.47B
Bilang ng mga empleyado
74K
Buksan
$149.70
Mataas
$152.34
Mababa
$144.91
Mkt. cap
358.21B
Avg. na dami
9.33M
Dami
0.00
Dividend
2.34%
Bawat tatlong buwang dividend
$0.85
Petsa ng ex-dividend
Set 15, 2026
P/E ratio
115.96
Mataas nang 52-wk
$156.92
Mababa nang 52-wk
$82.01
EPS
$1.25
Beta
0.21
Mga natitirang share
2.47B
Bilang ng mga empleyado
74K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Profile
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue. The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products. The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000. In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia
Tungkol sa Merck
CEORobert M Davis
Mga Empleyado74K
ItinatagEne 1, 1891
Headquarters-
Sektor-
Websitemerck.com
Mga rating ng analyst
Batay sa 21 (na) analyst na nagbigay ng mga rating ng stock sa MRK sa nakalipas na 3 buwan
Pagbili
Pagbili
15
Pag-hold
6
Pagbebenta
0
12 buwang forecas
Batay sa 21 (na) analyst sa Wall Street na nag-aalok ng mga target na presyo sa loob ng 12 buwan para sa MRK sa nakalipas na 3 buwan.
Pinakamataas
Kasalukuyan $145.19
$180.00 (+23.98%)
Average
$160.00 (+10.20%)
Pinakamababa
$105.00 (-27.68%)
Analyst
Rekomendasyon
Aksyon
Target na presyo
Inaasahan
Petsa
Mohit Bansal
Wells Fargo
Buy
Maintained
$165.00
+13.6%
10/15/2026
Evan Seigerman
BMO Capital
Buy
Maintained
$170.00
+17.1%
10/12/2026
Carter Gould
Cantor Fitzgerald
Hold
Maintained
$145.00
-0.1%
10/11/2026
Daina Graybosch
Leerink Partners
Buy
Maintained
$161.00
+10.9%
10/12/2026
Trung Huynh
RBC Capital
Hold
Reiterated
$145.00
-0.1%
10/12/2026
Geoff Meacham
Citi
Hold
Maintained
$145.00
-0.1%
10/13/2026
Emily Field
Barclays
Buy
Maintained
$150.00
+3.3%
10/12/2026
Michael Yee
UBS
Buy
Maintained
$175.00
+20.5%
10/09/2026
Jason Gerberry
Bank of America Securities
Buy
Maintained
$163.00
+12.3%
10/09/2026
Terence Flynn
Morgan Stanley
Buy
Maintained
$177.00
+21.9%
10/07/2026
Chris Schott
J.P. Morgan
Buy
Maintained
$165.00
+13.6%
10/05/2026
Asad Haider
Goldman Sachs
Buy
Maintained
$160.00
+10.2%
09/30/2026
Louise Chen
Scotiabank
Buy
Maintained
$180.00
+24%
09/29/2026
Steve Scala
TD Cowen
Hold
Maintained
$155.00
+6.8%
09/22/2026
Nico Chen
DBS
Buy
Maintained
$180.00
+24%
09/11/2026
Rajesh Kumar
HSBC
Buy
Maintained
$172.00
+18.5%
09/10/2026
Vamil Divan
Guggenheim
Buy
Reiterated
$170.00
+17.1%
09/08/2026
Courtney Breen
Bernstein
Hold
Maintained
$105.00
-27.7%
09/07/2026
Jasper Hellweg
Argus Research
Buy
Reiterated
$170.00
+17.1%
08/24/2026
Alexandria Hammond
Wolfe Research
Buy
Maintained
$180.00
+24%
08/25/2026
Luisa Hector
Berenberg Bank
Hold
Maintained
$127.00
-12.5%
08/05/2026
Unknown Analyst
Jefferies
Buy
Maintained
$138.00
-5%
05/19/2026
Unknown Analyst
Argus Research
Buy
Reiterated
$130.00
-10.5%
05/08/2026
Hans Engel
Erste Group
Hold
Maintained
-
-
05/05/2026
Natalya Davies
Rothschild & Co Redburn
Buy
Maintained
$179.00
+23.3%
04/17/2026
James Shin
Deutsche Bank
Buy
Upgraded
$150.00
+3.3%
02/13/2026
Susunod na tawag sa loob ng sa 13 araw
Huw, Okt 29, 3:00 PM
Fiscal period
Q3 2026
- / $2.09
Kita / Pagtataya (USD)
- / 17.31B
Earnings call para sa Fiscal Q3 2026
Hinihintay ang earnings call
Sa isang sulyap: mga paparating na kita
Mga insight mula sa mga pinakabagong balita at ulat
Mga nakaraang ulatLahat ng value sa USD
Loading Previous Earnings...
Kita
Net na kita
Lahat ng value sa USD
Set 2025
Dis 2025
Mar 2026
Hun 2026
Kita
17.28B
16.40B
16.29B
16.61B
Gastusin sa mga naibentang produkto
3.74B
4.30B
3.88B
4.13B
Halaga ng kita
3.74B
4.30B
3.88B
4.13B
Mga gastos sa pananaliksik at pag-develop
4.00B
4.00B
3.56B
9.74B
Kabuuang gastos sa pananaliksik at pag-develop
-
-
-
-
Mga gastos sa pagbebenta, pangkalahatan, at admin
2.48B
2.73B
2.57B
2.78B
Gastos sa pagpapatakbo
6.48B
6.73B
6.12B
12.52B
Kabuuang gastos sa pagpapatakbo
10.23B
11.02B
10.00B
16.65B
Kita sa pagpapatakbo
7.05B
5.38B
6.29B
-40.00M
Iba pang hindi kita sa pagpapatakbo
-
41.00M
42.00M
59.00M
EBT na may mga hindi karaniwang item
6.74B
3.42B
-3.53B
-683.00M
EBT na hindi kasama ang mga hindi karaniwang item
6.76B
4.98B
5.85B
-508.00M
Gastos sa buwis sa kita
958.00M
458.00M
709.00M
654.00M
Epektibong rate ng buwis
14.20%
13.39%
-20.06%
-95.75%
Iba pang gastos sa pagpapatakbo
-
-
-
-
Net na kita
5.78B
2.96B
-4.24B
-1.34B
Margin ng kabuuang kita
33.49%
18.07%
-26.03%
-8.04%
Kita bawat share
2.58
2.04
-1.28
-0.13
Kita sa interes at investment
96.00M
69.00M
35.00M
35.00M
Gastos sa interes
-327.00M
-411.00M
-479.00M
-525.00M
Mga net na gastos sa interes
-231.00M
-342.00M
-444.00M
-490.00M
Mga singil sa depreciation at amortization
-
-
-
-
EBITDA
8.15B
6.79B
7.69B
1.43B
Kita o pagkalugi mula sa pagbebenta ng mga asset
-
-
-
-
Mga transaksyon ng insider
Kinukuha ang data ng mga insider na transaksyon mula sa mga third-party na source. Matuto pa
Insider
Posisyon
Uri
Petsa
Mga Share
Halaga
Page 1
Posibleng magkaroon ng mga pagkakamali ang AI content. Matuto pa
Mga app ng Google